D 75N95020Q00153_CSS.pdf

COMBINED SYNOPSIS / SOLICITTION

75N95020Q00153

TITLE: Molecular Devices ImageXpress System Upgrade

(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotations are being requested and a written solicitation will not be issued.

(ii) The solicitation number is 75N95020Q00153 and the solicitation is issued as a request for quotation (RFQ). This acquisition is for a commercial item and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13—Simplified Acquisition Procedures, FAR Subpart 13.5 – Simplified Procedures for Certain Commercial Items, and FAR Part 12—Acquisition of Commercial Items. This acquisition is expected to exceed the simplified acquisition threshold.

(iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2020-06, dated June 5, 2020.

(iv) The associated NAICS code is 334516 and the Small Business size standard is 1,000 employees. This requirement is non-competitive. No set aside restrictions are applicable.

(v) THIS IS A NON-COMPETITIVE (NOTICE OF INTENT) COMBINED SYNOPSIS

SOLICITATION TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT

PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME).

The National Institute on Drug Abuse (NIDA), on behalf of the National Center for Advancing Translational Sciences (NCATS) intends to negotiate and award a purchase order without providing for full and open competition (including brand name) to molecular Devices, LLC, 3860 N First St., San Jose, CA 95134-1702, or an authorized distributor thereof. The determination by the Government to award a contract without providing for full and open competition is based upon the market research conducted that identified no other sources of supply or service capable of achieving this Government requirement within the required time frame.

This acquisition is conducted as non-competitive for a commercial item or service and is conducted pursuant to FAR Subpart 13.5 - Simplified Procedures for Certain Commercial Items and FAR 13.501, Special Documentation Requirements, in accordance with 41 United States Code (U.S.C.) 1901. Pursuant to FAR Subpart 13.501(a)(1)(iv) the brand-name justification is made publicly available as an attachment with this solicitation.

DESCRIPTION

(vi) The National Center for Advancing Translational Sciences (NCATS) at the National

Institutes of Health (NIH) seeks to upgrade one of its Molecular Devices ImageXpress Systems to enable performance of optogenetic screening of neural response to drugs and other stimulants in order to seek out treatments for opioid abuse. This upgrade is essential to investigate neural response and will allow scientists to screen human cell-based models of opioid misuse, addiction, and pain for the Helping to End Addiction Long-term (HEAL) Initiative.

The specific upgrades that NCATS requires includes the following:

Line Item No. Description

1 One high-performance 7 line laser light source. Laser safe fluidics for IXMC including EC. UV/Vis Absorbance Spectra

2 Asynchronous dispense software that provides simultaneous dispense and imaging for IXM fluidic versions.

3 Installation 4 Operational training from Molecular Devices qualified technician

(vii) The anticipated delivery date is two months from the date of award. Delivery shall be made to the below address, FOB Destination. Installation and training shall occur as soon as practicable after delivery, on a date and time agreed upon by NCATS and the contractor.

9800 Medical Center Drive Rockville, MD 20850

(viii) The anticipated award date is July 8, 2020.

(ix) The Government plans to award a contract resulting from this solicitation. The resulting award will be made to the responsible offeror whose offer will be most advantageous to the Government, price and other factors considered. The following factors shall be used to evaluate quotations: Technical Capability, Past Performance, and Price. Comparative evaluations will be conducted if multiple quotations are received.

SUBMISSION INSTRUCTIONS

(x) All responses to this RFQ must be received by 8:59am Eastern Time on Monday, July 6, 2020 and must reference the solicitation number cited above. Responses must be submitted via email to Kimberly Espinosa at kimberly.espinosa@nih.gov.

(xi) This is an RFQ. This request does not commit the Government to pay any costs incurred in the preparation of the submission of this quotation or to contract for supplies or service.

mailto:kimberly.espinosa@nih.gov

Supplies are of domestic origin unless otherwise indicated by quoter. Any representations and/or certifications attached to this RFQ must be completed by the quoter.

(xii) Responses to this RFQ must include sufficient information to establish the interested parties’ bona-fide capabilities of providing the product or service. Responses must also include the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), the certification of business size, and the completed representation in FAR Provision 52.204-24 (attached).

(xiii) The response shall contain a quotation that includes the total price, as well as: the unit price, list price, shipping and handling costs, delivery days after contract award, delivery terms, prompt payment discount terms, product or catalog number(s), product description, and any other information or factors that may be considered in the award decision. Such factors may include: past performance; special features required for effective program performance; trade-in considerations; probable life of the item selected as compared with that of a comparable item; warranty considerations; maintenance availability; and environmental and energy efficiency considerations.

(xiv) Respondents that believe that they are manufacturers or authorized resellers of the brand-name product specified in this announcement must provide, as part of their response: (a) product, catalog, model, and/or part number(s); (b) product description; (c) all relevant information and documentation that the item(s) offered meets the salient physical, functional, or performance characteristics as specified in the purchase description; quantity;

estimated price or cost; shipping, handling, and/or installation charges; and delivery date after receipt of order.

(xv) All responsible sources may submit a bid, proposal, or quotation which shall be considered by the agency.

(xvi) For information about this RFQ, contact Kimberly Espinosa, Contracting Officer, at 301-

827-3546 or kimberly.espinosa@nih.gov.

TERMS AND CONDITIONS, PROVISIONS, AND REPRESENTATIONS

(xvii) The provision at FAR 52.252-1, Solicitation Provisions Incorporated by Reference (Feb

1998). This solicitation incorporates one or more solicitation provisions by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. The offeror is cautioned that the listed provisions may include blocks that must be completed by the offeror and submitted with its quotation or offer. In lieu of submitting the full text of those provisions, the offeror may identify the provision by paragraph identifier and provide the appropriate information with its quotation or offer. Also, the full text of a solicitation provision may be accessed electronically at www.acquisition.gov.

The following provisions apply to this acquisition and are incorporated by reference:

1. The provision at FAR 52.204-7, System for Award Management (Oct 2018)

2. The provision at FAR 52.204-16, Commercial and Government Entity Code Reporting

(Jul 2016)

4. The provision at FAR 52.212-1, Instructions to Offerors – Commercial Items (Oct 2018)

5. The provision at FAR 52.212-2 Evaluation—Commercial Items (Oct 2014)

6. The provision at FAR 52.212-3, Offeror Representations and Certifications—Commercial

Items (Dec 2019)

7. The provision at FAR 52.225-2, Buy American Certificate (May 2014)

(xviii) The clause at FAR 52.252-2, Clauses Incorporated by Reference (Feb 1998). This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at www.acquisition.gov or https://www.hhs.gov/grants/contracts/contract-policies-regulations/hhsar/index.html.

In addition to the clauses checked in FAR 52.212-5 (attached), the following clauses also apply to this acquisition and are incorporated by reference:

1. The clause at FAR 52.204-13, System for Award Management Maintenance (Oct 2018)

2. The clause at FAR 52.204-18, Commercial and Government Entity Code Maintenance

(Jul 2016)

3. The clause at FAR 52.212-4, Contract Terms and Conditions – Commercial Items (Oct

2018)

4. The clause at HHSAR 352.222-70, Contractor Cooperation in Equal Employment

Opportunity Investigations (December 18, 2015)

(xix) The Defense Priorities and Allocations System (DPAS) are not applicable to this requirement.

(xx) There are no additional contract requirement(s) or terms and conditions applicable to this acquisition.

ATTACHMENTS

(xxi) The following apply to this acquisition and are attached in full text:

1. Justification for Other than Full and Open Competition

2. The clause at FAR 52.212-5, Contract Terms and Conditions Required to Implement

Statutes or Executive Orders–Commercial Items (June 2020)

3. The provision at FAR 52.204-24, Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment (Dec 2019)

4. NIH Invoice and Payment Provisions (2/2014)

5. NIH Electronic Invoice Submission Instructions (4/2020)